Open AccessResults of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer
Author(s) -
P. Ahn,
M. Machtay,
P. Anné,
E. Wuthrick,
W KEANE,
D. Cognetti,
Adam P. Dicker,
R. Axelrod
Publication year - 2010
Language(s) - English
DOI - 10.29046/tbj.003.1.021
Subject(s) - erlotinib , docetaxel , bevacizumab , medicine , cisplatin , oncology , head and neck cancer , radiation therapy , erlotinib hydrochloride , cancer , chemotherapy , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom